In The News

In The News

71 Results found
71 Results found

Waldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint

Obagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel

Waldencast Announces Sale of Obagi Medical to Bridgepoint

Waldencast announces conclusion of SEC investigation

Waldencast Reports Q4 2025 and FY 2025 Financial Results

Obagi Medical Unveils ALOHA Program to Launch Obagi® saypha® MagIQ™

Waldencast Announces Q2 2025 Results and Provides Q3 2025 Trading Update

Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting